Similar articles

• Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.

  Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P. Reboldi G, et al. J Hypertens. 2008 Jul;26(7):1282-9. doi: 10.1097/HJH.0b013e328306ebe2. J Hypertens. 2008. PMID: 18550998
• An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.

  Nowacki P, Porebska A, Bajer-Czajkowska A, Zywica A, Koziarska D, Podbielski J. Nowacki P, et al. Ann Acad Med Stetin. 2007;53(2):14-9. Ann Acad Med Stetin. 2007. PMID: 18557372
• Renin-angiotensin-system blockade in the prevention of diabetes.

  Ostergren J. Ostergren J. Diabetes Res Clin Pract. 2007 May;76 Suppl 1:S13-21. doi: 10.1016/j.diabres.2007.01.018. Epub 2007 Feb 23. Diabetes Res Clin Pract. 2007. PMID: 17320999 Review.
• Reducing diabetes incidence through the inhibition of the renin-angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?

  Zanolla L, Vassanelli C. Zanolla L, et al. J Cardiovasc Med (Hagerstown). 2007 Jul;8(7):473-82. doi: 10.2459/01.JCM.0000278445.04613.27. J Cardiovasc Med (Hagerstown). 2007. PMID: 17568278 Review.
• Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.

  Lip GY, Frison L, Grind M. Lip GY, et al. J Intern Med. 2007 Jun;261(6):577-86. doi: 10.1111/j.1365-2796.2007.01780.x. J Intern Med. 2007. PMID: 17547713